Skip to content

Clinical study on neuromodulation therapy of spinal cord electrical stimulation

Clinical study on neuromodulation therapy of spinal cord electrical stimulation

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035541
Enrollment
Unknown
Registered
2020-08-13
Start date
2020-08-13
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Peripheral Neuropathy

Interventions

Sponsors

Shanghai Tenth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years old; 2. Clinically diagnosed as diabetic peripheral neuropathy; 3. After several oral medications, the treatment effect of peripheral sympathetic nerve regulation is not good.

Exclusion criteria

Exclusion criteria: 1. Undergone neuromodulation therapy within 3 months before; 2. Neuropathy or chronic pain from other sources other than diabetic peripheral neuropathy; 3. Use opioids or abuse drugs or alcohol; 4. Blood coagulation disorders; 5. Known immunodeficiency; 6. Peripheral vascular disease; 7. Active ulcer; 8. Severe heart or lung disease; 9. Unstable blood sugar control (HbA1c change >=1% within three months); 10. Hyperthyroidism, hypothyroidism; 11. Cervical disc herniation, lumbar disc herniation; 12. Those with a history of mental illness and those who do not cooperate.

Design outcomes

Primary

MeasureTime frame
VAS scale;Mcgill Pain Score;

Countries

China

Contacts

Public ContactFuqing Lin

Shanghai Tenth Hospital

15800552155@163.com+86 18917684132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026